MediCarbone will be in attendance at the Orthopedic Research Society Annual Meeting (ORS), February 2-6, 2024 at the Long Beach Convention Center in Long Beach, CA. The ORS Annual Meeting brings the orthopedic community together for five days of workshops, learning sessions, networking, and advocacy. In addition to the education and fun, attendees can also
MediCarbone has 1 licensed patent from the University of Arizona; 2 patents approved for publishing and many other patents in the works Compositions and methods for treating bone fractures Systems and methods for bone repair and management using biocompatible polymeric resin Methods for creating, inserting and removing an intramedullary sleeve system for bone treatment
MediCarbone announced it received an NSF SBIR Phase I award for $273,563 for the design and development of its minimally-invasive orthopedic fracture fixation technology, which uses an intramedullary sleeve and injectable, light-triggered bone cement. "We are thrilled to have received the NSF Award to further our groundbreaking, carbon-fiber-reinforced polymer application—which will
UAVenture Capital Fund II LLC, an investment fund managed by UAVenture Capital LLC, invested in MediCarbone Inc. Financial terms of the investments were not disclosed. The investments are expected to help with technology development of MediCarbone's unique, minimally-invasive orthopedic fracture fixation technology, which uses an intramedullary sleeve and injectable, light-triggered bone cement. UAVenture Capital
